Recruiting
Phase 2
Phase 3

RAPA-501

Sponsor:

Rapa Therapeutics LLC

Code:

NCT04220190

Conditions

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RAPA-501 Autologous T stem cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Rapa Therapeutics LLC on 2025-06-18.